Delivery Order SPE2DB20D3505-SPE2DB24FT8J4
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,728,779 units of the prescription medication Vyvanse 40 mg capsules. The contract has a ceiling value of $2,675.40 and a period of performance through December 17, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.95 firm-fixed-price delivery order is for the supply of 4,566,340,680 units of the prescription drug Vyvanse 40 mg capsules. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,179,118 units of the prescription drug Vyvanse 30 mg capsules. The $1,150.57 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is a defense agency, and has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,978,188 units of Vyvanse 40 mg capsules. The $1,567.08 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, and has a completion date of June 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,359,320 units of Vyvanse 50 mg capsules. The contract has a ceiling value of $4,006.50 and is a firm-fixed price delivery order, with a period of performance through November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,103.02 firm fixed-price delivery order is for the supply of 4,568,072,848 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 29, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,986.64 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,198,098 units of the medication Vyvanse 40 mg capsules. The contract has a firm fixed-price pricing type and an ultimate completion date of October 25, 2024. This award is a task order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award, valued at $12,380.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,225,719 units of the prescription drug Vyvanse 40 mg capsules over a 3-year period ending in October 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This federal contract award is for the delivery of 4,565,153,938 units of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on a firm fixed-price basis with a ceiling value of $6,580.88. The contract has a period of performance through July 16, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT8J4Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,830,861 units of the prescription medication Vyvanse 40 mg capsules. The $1,463.48 firm fixed-price Delivery Order has a completion date of March 4, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 3/1/24 |